Zenapax and effect on clinical outcome of hepatitis C post liver transplant
โ Scribed by Islam, Khondker K.; Rustgi, Vinod K.; Kuo, Paul C.; Plotkin, Jeffrey S.; Kim, Kyung; Johnson, Lynt B.
- Book ID
- 122387124
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 177 KB
- Volume
- 118
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Hepatitis frequently recurs after liver transplantation for early recurrence is associated with a higher risk of disease progression. (HEPATOLOGY 1997;26:1646-1652.) hepatitis C. However, the histological progression of disease, predictors of recurrence and disease severity, and patient survival rem
Hepatitis B (HBV) and C viral (HCV) dual-infectionassociated liver disease is an uncommon indication for liver transplantation. The clinical and virologic outcomes in such patients have not been well studied. We retrospectively studied 13 patients with hepatitis B surface antigen (HBsAg) and antibod